226260-01-1

Basic information

• Product Name: 3-FLUORO-N-METHOXY-N-METHYLBENZAMIDE
• Synonyms: 3-FLUORO-N-METHOXY-N-METHYLBENZAMIDE
• CAS NO: 226260-01-1
• Molecular Formula: C₉H₁₀FNO₂
• Molecular Weight: 183.18
• Mol File: 226260-01-1.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 300.5 °C at 760 mmHg
• Flash Point: 135.5 °C
• Appearance: /
• Density: 1.179 g/cm³
• Vapor Pressure: 0.00112mmHg at 25°C
• Refractive Index: 1.509
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 3-FLUORO-N-METHOXY-N-METHYLBENZAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-FLUORO-N-METHOXY-N-METHYLBENZAMIDE(226260-01-1)
• EPA Substance Registry System: 3-FLUORO-N-METHOXY-N-METHYLBENZAMIDE(226260-01-1)

Safety Data

• Hazardous Substances Data: 226260-01-1(Hazardous Substances Data)

Usage

General Description

3-Fluoro-N-methoxy-N-methylbenzamide is a chemical compound with the molecular formula C9H10FNO2. It features the chemistry of fluorine, which imparts a range of unique properties including stability, reactivity, and the ability to form strong bonds with other elements. The presence of the amide group (-CONH2) suggests that this compound could participate in hydrogen bonding and other interactions, which are crucial to its reactivity and possible applications. As an organic compound containing both an amide and methoxy group, it has potential use in a variety of chemical reactions within fields such as pharmaceuticals or materials development. However, detailed information about its synthesis, properties, and specific applications are not widely available in literature, indicating it may be primarily a niche or research-focused chemical.

InChI:InChI=1/C9H10FNO2/c1-11(13-2)9(12)7-4-3-5-8(10)6-7/h3-6H,1-2H3

Upstream product

• 455-38-9 3-fluorobenzoic acid 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 1711-07-5 3-fluorobenzoyl chloride 
• 1892-57-5 N-(3-dimethylaminopropyl)-N-ethylcarbodiimide 
• 1117-97-1 N,0-dimethylhydroxylamine 

Downstream Products

• 177560-78-0 1-(3-fluorophenyl)-2-[4-(methylsulfanyl)phenyl]-1-ethanone 
• 926931-57-9 1-(3-fluorophenyl)-3-(methoxymethylamino)propan-1-one 
• 75762-58-2 (3-bromophenyl)-(3-fluorophenyl)methanone 
• 455-36-7 1-(3-fluorophenyl)ethanone 
• 1421319-47-2 5-fluoro-2-hydroxy-N-methoxy-N-methylbenzamide 
• 1421319-48-3 3-fluoro-2-hydroxy-N-methoxy-N-methylbenzamide 
• 1628416-28-3 2-(7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2(1H)-yl)-N-methyl-N-(2-methylbenzo[d]oxazol-6-yl)acetamide 
• 345-70-0 3,3'-difluorobenzophenone 

Relevant articles and documents

HETEROARYL DERIVATIVE, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE COMPONENT

The present invention relates to a 6-(isooxazolidin-2-yl)-N-phenylpyrimidin-4-amine derivative, and a pharmaceutical composition for preventing or treating cancer comprising the compound as an effective component. The compound exhibits high inhibitory activity against an epidermal growth factor receptor (EGFR) variant, or wild-type or variants of one or more of ERBB2 and ERBB4, and thus may be usefully used in the treatment of cancers in which same are expressed. In particular, the compound exhibits excellent inhibitory activity on proliferation of lung cancer cell lines, and can thus be usefully used in the treatment of lung cancer.

AZA-PYRIDONE COMPOUNDS AND USES THEREOF

Disclosed herein are aza-pyridone compounds, pharmaceutical compositions that include one or more aza-pyridone compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an orthomyxovirus infection, with an aza-pyridone compound. Examples of an orthomyxovirus viral infection include an influenza infection.

PHTHALAZINONE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

The invention relates to a compound of Formula I and methods of treating CFTR (cystic fibrosis transmembrane conductance regulator) mediated diseases, in particular cystic fibrosis, comprising the step of administering a therapeutically effective amount o